June 25, 2010. University of Illinois at Chicago participated in a multicenter, international for newly diagnosed patients, the most common type of aggressive brain tumor, glioblastoma multiforme glioblastoma multiforme, which is supported by the use of medical devices that apply an electric field of the brain.
Clinical trials will evaluate the safety and effectiveness of research tools that target the cancer cells are growing rapidly with the frequency of the electric field. Treatment with the device will be tested in combination with standard therapy and maintenance therapy compared with standard care alone.
The Novo-TTF is a non-invasive medical devices that change the distribution of cells in brain cancer with an alternating electric field is called “tumor treating fields,” sent to the surface of the scalp electrodes isolated.